Delcath Systems Announces New Data Presented at ESMO 2024 Demonstrating Efficacy of HEPZATO KIT in Metastatic Uveal Melanoma Subgroups

DCTH Stock  USD 11.01  0.17  1.52%   
Under 61% of Delcath Systems' investor base is looking to short. The analysis of overall sentiment of trading Delcath Systems stock suggests that many investors are alarmed at this time. Delcath Systems' investing sentiment shows overall attitude of investors towards Delcath Systems.
  
Delcath Systems, Inc. , an interventional oncology company focused on liver-directed cancer therapies, today announced the presentation

Read at businesswire.com
businesswire News
  

Delcath Systems Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Delcath Systems can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Delcath Systems Fundamental Analysis

We analyze Delcath Systems' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Delcath Systems using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Delcath Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Retained Earnings

Retained Earnings Comparative Analysis

Delcath Systems is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

Delcath Systems Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Delcath Systems stock to make a market-neutral strategy. Peer analysis of Delcath Systems could also be used in its relative valuation, which is a method of valuing Delcath Systems by comparing valuation metrics with similar companies.

Peers

Delcath Systems Related Equities

SGHTSight Sciences   6.25   
0%
100.0%
CLPTClearpoint Neuro   6.07   
0%
97.0%
LUNGPulmonx Corp   3.71   
0%
59.0%
NPCENeuropace   3.50   
0%
56.0%
CVRXCVRx   3.33   
0%
53.0%
RCELAvita Medical   2.53   
0%
40.0%
IRMDIradimed   2.44   
0%
39.0%
TMDXTransMedics   1.93   
0%
30.0%
TELATela Bio   1.79   
0%
28.0%
OFIXOrthofix Medical   1.40   
0%
22.0%
ELMDElectromed   0.91   
0%
14.0%
TMCITreace Medical   0.87   
0%
13.0%
ITGRInteger Holdings   0.59   
0%
9.0%
LIVNLivaNova PLC   0.21   
0%
3.0%
SRDXSurModics   0.40   
6.0%
0%
KIDSOrthopediatrics Corp   0.93   
14.0%
0%

Complementary Tools for Delcath Stock analysis

When running Delcath Systems' price analysis, check to measure Delcath Systems' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Delcath Systems is operating at the current time. Most of Delcath Systems' value examination focuses on studying past and present price action to predict the probability of Delcath Systems' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Delcath Systems' price. Additionally, you may evaluate how the addition of Delcath Systems to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Bonds Directory
Find actively traded corporate debentures issued by US companies
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Fundamental Analysis
View fundamental data based on most recent published financial statements